- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 261/06 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 261/06
Total number of patents in this class: 84
10-year publication summary
|
0
|
5
|
3
|
6
|
3
|
4
|
4
|
3
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 676 |
5 |
| Firmenich Incorporated | 138 |
4 |
| Aldeyra Therapeutics, Inc. | 108 |
3 |
| Corteva Agriscience LLC | 2682 |
3 |
| Amgen Inc. | 3911 |
2 |
| Amira Pharmaceuticals, Inc. | 70 |
2 |
| Enanta Pharmaceuticals, Inc. | 427 |
2 |
| Indiana University Research and Technology Corporation | 799 |
2 |
| Lexicon Pharmaceuticals, Inc. | 204 |
2 |
| Medshine Discovery Inc. | 610 |
2 |
| The Scripps Research Institute | 1353 |
2 |
| University of Massachusetts | 2198 |
2 |
| Guangdong Raynovent Biotech Co., Ltd. | 44 |
2 |
| Glaxosmithkline LLC | 539 |
1 |
| The Regents of the University of California | 19590 |
1 |
| Boehringer Ingelheim International GmbH | 4748 |
1 |
| Sumitomo Chemical Company, Limited | 9008 |
1 |
| Board of Regents, The University of Texas System | 5648 |
1 |
| Abbvie Inc. | 1786 |
1 |
| Mayo Foundation for Medical Education and Research | 3126 |
1 |
| Other owners | 44 |